Oliver Wyman Enters Into Agreement to Acquire Avascent

Deal Combines Leading Aerospace and Defense Firm into Oliver Wyman

Global management consulting firm Oliver Wyman, a business of Marsh McLennan [NYSE: MMC], announced that it has entered into an agreement to acquire Avascent, an Aerospace and Defense (A&D) management consulting firm focused on the corporate and private equity sectors.

Avascent complements Oliver Wyman's strong position and reputation across the aviation, aerospace and defense industry globally. For more than fifteen years, Avascent has been the preeminent specialist management consulting firm serving clients across aerospace, defense, and government sectors. Avascent is also the leading boutique private equity and M&A advisor in the A&D space and the combination of Avascent and Oliver Wyman will create a team with unparalleled experience in both deal and post-transaction work.